Tejchman Karol, Nowacki Adam, Kotfis Katarzyna, Skwirczynska Edyta, Kotowski Maciej, Zair Labib, Ostrowski Marek, Sienko Jerzy
Department of General and Transplantation Surgery, Pomeranian Medical University, 70-111 Szczecin, Poland.
Department of Vascular and General Surgery, Pomeranian Medical University, 70-111 Szczecin, Poland.
Biomedicines. 2021 Apr 13;9(4):417. doi: 10.3390/biomedicines9040417.
Ischemia-reperfusion injury (IRI) occurring after renal transplantation is a complex biochemical process that can be monitored by specific biomarkers. The roles of those are not yet fully elucidated. The aim of this study was to analyze the concentrations of endothelins (ET-1, ET-2, and ET-3), interleukin-18 (IL-18), and neutrophil gelatinase-associated lipocalin (NGAL) during the reperfusion of human kidneys grafted from brain dead donors and later transplanted. The study group ( = 44) was analyzed according to the method of kidney storage: Group 1 underwent hypothermic machine perfusion (HMP) in the LifePort perfusion pump ( = 22), and Group 2 underwent static cold storage (SCS) ( = 22). The analysis of kidney function was performed daily during the first seven days after transplantation. The kidneys in Group 1 were characterized by higher absolute concentrations of ET-1, IL-18, and NGAL, as well as a lower concentration of ET-2 ( = 0.017) and ET-3. The relative increase of ET-1 ( = 0.033), ET-2, and ET-3 during reperfusion was lower in this group, while the relative decrease of NGAL was higher. Group 1 was also characterized by significant decrease of IL-18 ( = 0.026) and a tendency for better kidney function based on the higher total diuresis, higher glomerular filtration rate (GFR), higher potassium level, lower serum creatinine, and lower urea concentration during the seven-day postoperative observation period. The long-term beneficial impact of hypothermic machine perfusion on the outcome of transplanted kidneys may rely on the early modified proceedings and intensity of ischemia-reperfusion injury reflected by the dynamics of the concentrations of examined biomarkers.
肾移植后发生的缺血再灌注损伤(IRI)是一个复杂的生化过程,可通过特定生物标志物进行监测。这些生物标志物的作用尚未完全阐明。本研究的目的是分析从脑死亡供体获取并随后移植的人类肾脏再灌注期间内皮素(ET-1、ET-2和ET-3)、白细胞介素-18(IL-18)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)的浓度。根据肾脏保存方法对研究组(n = 44)进行分析:第1组在LifePort灌注泵中进行低温机器灌注(HMP)(n = 22),第2组进行静态冷藏(SCS)(n = 22)。移植后的前七天每天进行肾功能分析。第1组的肾脏特点是ET-1、IL-18和NGAL的绝对浓度较高,而ET-2(P = 0.017)和ET-3的浓度较低。该组再灌注期间ET-1(P = 0.033)、ET-2和ET-3的相对增加较低,而NGAL的相对减少较高。第1组的另一个特点是IL-18显著降低(P = 0.026),并且在术后七天观察期内,基于较高的总尿量、较高的肾小球滤过率(GFR)、较高的钾水平、较低的血清肌酐和较低的尿素浓度,肾功能有改善的趋势。低温机器灌注对移植肾脏结局的长期有益影响可能依赖于早期的改变过程以及由所检测生物标志物浓度动态反映的缺血再灌注损伤强度。